ClotX Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
ClotX General Information
Description
Manufacture of thrombosis treatment product based in Basel, Swaziland. The company product is designed to improve thrombosis care by removing the thrombus and minimizing peripheral adverse effects during the treatment process, enabling businesses to improve patient care and overall quality of life.
Contact Information
Corporate Office
- Basel
- Switzerland
Corporate Office
- Basel
- Switzerland
ClotX Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Accelerator/Incubator | 01-Jan-2023 | Completed | Startup |
ClotX Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
DayOne Accelerator | Accelerator/Incubator |
ClotX FAQs
-
Where is ClotX headquartered?
ClotX is headquartered in Basel, Switzerland.
-
What industry is ClotX in?
ClotX’s primary industry is Other Devices and Supplies.
-
Is ClotX a private or public company?
ClotX is a Private company.
-
What is ClotX’s current revenue?
The current revenue for ClotX is
. -
Who are ClotX’s investors?
DayOne Accelerator has invested in ClotX.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »